7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Codiak BioSciences, Inc
(NASDAQ:CDAK) 

CDAK stock logo

Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12, an ...

Founded: 2015
Full Time Employees: 105 (May 2021)
Sector: Healthcare
Industry: Biotechnology
Healthcare
Share this website to your friends
Codiak BioSciences Days Payable Outstanding ttm (DPO)
202211 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 022.6245.2567.8790.5113.12135.75158.37
Codiak BioSciences Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 02.935.868.7911.7214.6517.5820.51
Codiak BioSciences Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3.4-2.92-2.43-1.94-1.46-0.97-0.490
Codiak BioSciences Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3.55-3.04-2.54-2.03-1.52-1.01-0.510
Codiak BioSciences Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.51.011.512.022.523.033.53
Codiak BioSciences P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.260.520.781.041.31.561.82
Codiak BioSciences (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.93-0.8-0.66-0.53-0.4-0.27-0.130
Codiak BioSciences P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.120.250.370.50.620.750.87
No extra charts and metrics for this ticker.